COMMUNIQUÉS West-GlobeNewswire

N.M. Judge Rejects NMDOH Sanction for Seedling at State Fair
11/06/2018
Judge David K. Thomson rules NMDOH sanction is arbitrary and capricious SANTA FE, N.M., June 11, 2018 (GLOBE NEWSWIRE) -- District Judge David. K Thomson reversed the New Mexico Department of Health (NMDOH) sanction [...]
Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index
11/06/2018
CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Clearside Biomedical to Participate in 2018 JMP Securities Life Sciences Conference
11/06/2018
ALPHARETTA, Ga., June 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Improve Health of Mothers and Babies
11/06/2018
WALTHAM, Mass. and WHITE PLAINS, N.Y., June 11, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and March of Dimes today announced a strategic corporate partnership focused on a shared commitment to [...]
PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference
11/06/2018
HOUSTON, June 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg [...]
Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares
11/06/2018
YARDLEY, Pa., June 11, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today the closing of its underwritten public offering of 5,750,000 of its common shares at a price to the public of $22.25 per [...]
Immunomedics Announces Proposed Public Offering of Common Stock
11/06/2018
MORRIS PLAINS, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Medigus Ltd Announces First Quarter 2018 Financial Results
11/06/2018
OMER, Israel, June 11, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct [...]
Trevena Expands Commercial and Medical Affairs Leadership Teams with Key Hires
11/06/2018
CHESTERBROOK, Pa., June 11, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) announced today the recent additions of three key members to its leadership team. The Company has appointed Linda Wase, M.D. as Vice [...]
Pulse Systems Announces Upgraded ISO 13485:2016 and ISO 9001:2015 Certifications
11/06/2018
Medical industry supplier attains newest revisions for the quality systems utilized to manufacture precision device components CONCORD, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Pulse Systems, today announced, the [...]
Ossur Hf : Transactions in relation to share buyback program
11/06/2018
Announcement no. 39/2018 Reykjavik, 11 June 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
11/06/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
11/06/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Bradmer Pharmaceuticals Cancels Meeting of Subscription Receipt Holders
11/06/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. TORONTO, June 11, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (“ Bradmer ” or the “ Company ”) (TSX VENTURE:BMR.H) [...]
Tivity Health to Present at the William Blair 38th Annual Growth Stock Conference
11/06/2018
NASHVILLE, Tenn., June 11, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ:TVTY) will present at the William Blair 38 th Annual Growth Stock Conference to be held June 12-14, 2018, in Chicago. Donato Tramuto, [...]
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
11/06/2018
Operations are Anticipated to Continually Increase, Which Includes Volume and Pricing, While it Prepares to Launch Its More Profitable Aggregate Operations TORONTO, ON, June 11, 2018 (GLOBE NEWSWIRE) -- Easton [...]
BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program
11/06/2018
MELVILLE, N.Y., June 11, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today reported the findings [...]
DRAFT RESOLUTIONS of Annual General Meeting of Shareholders of joint stock company “Grindeks” to be held on 26 June 2018
11/06/2018
Approved at the meeting of the Board of joint stock company “Grindeks” on 11 June 2018 and revised at the meeting of the Supervisory Council of joint stock company “Grindeks” on 11 June 2018 DRAFT RESOLUTIONS of Annual [...]
Aquinox Pharmaceuticals Announces Initiation of ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor in CP/CPPS
11/06/2018
- Trial Will Enroll Approximately 100 Male Subjects in the US and Canada - VANCOUVER, British Columbia, June 11, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage [...]

Pages